Mystic has established strategic alliances to support its efforts in intranasal and ophthalmic drug formulation, clinical research, manufacturing and distribution in the US and key international markets in Asia and Europe.

We are actively seeking joint venture and licensing partners interested in:

• Preservative free, unit dose ophthalmic or
    intranasal drug delivery for new or existing
    drugs or biologics

• Product life extension for drugs coming off
    patent through the use of proprietary
    drug delivery systems

• Collaborative ventures to combine generic drugs or
    biologic agents with novel ophthalmic or intranasal delivery systems

• Lyophilized drug delivery

For additional information please contact us